SFDA approves registration of Pemazyre for cholangiocarcinoma

November 11, 2025

Saudi Gazette reportRIYADH — The Saudi Meals and Drug Authority (SFDA) has authorized the registration of Pemazyre (Pemigatinib) as a monotherapy for adults with regionally superior or metastatic cholangiocarcinoma.

Supply hyperlink

Is Casemiro leaving Manchester United? The Purple Devils linked to former Actual Madrid market goal

Saudi Arabia, Kuwait signal 4 MoUs for bolstering bilateral ties

Popular

SFDA approves registration of Pemazyre for cholangiocarcinoma

Subscribe

DSV expands in Dubai with new 30,000 sqm logistics warehouse in Jebel Ali Free Zone, developed by Arcapita’s Lintara

Tawakkalna Allows Digital Hajj Permits for Pilgrims and Employees

Gold Jewellery of Abbasid-Period Found at Diriyyah Web site in Saudi Arabia

stc group prepares for Hajj 1447 AH with superior options and an built-in connectivity ecosystem

Saudi Awwal Financial institution indicators SR6.4 billion financing settlement with AlBawani

More like this
Related

DSV expands in Dubai with new 30,000 sqm logistics warehouse in Jebel Ali Free Zone, developed by Arcapita’s Lintara

Tawakkalna Allows Digital Hajj Permits for Pilgrims and Employees

Gold Jewellery of Abbasid-Period Found at Diriyyah Web site in Saudi Arabia

stc group prepares for Hajj 1447 AH with superior options and an built-in connectivity ecosystem

About us

The latest

DSV expands in Dubai with new 30,000 sqm logistics warehouse in Jebel Ali Free Zone, developed by Arcapita’s Lintara

Tawakkalna Allows Digital Hajj Permits for Pilgrims and Employees

Gold Jewellery of Abbasid-Period Found at Diriyyah Web site in Saudi Arabia

Subscribe

SFDA approves registration of Pemazyre for cholangiocarcinoma

Subscribe

More like thisRelated

About us

The latest

Subscribe

More like this
Related